Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline and GLP study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2014
Report date:
2014

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
GLP compliance:
yes (incl. QA statement)
Remarks:
testing lab.

Test material

Constituent 1
Chemical structure
Reference substance name:
8-(benzoyloxy)naphthalen-1-yl benzoate
EC Number:
810-797-4
Cas Number:
331711-99-0
Molecular formula:
C24 H16 O4
IUPAC Name:
8-(benzoyloxy)naphthalen-1-yl benzoate
Details on test material:
- Name of test material (as cited in study report): Thane 003-6
- Physical state: solid
- Analytical purity: approx. 98.153%
- Test substance No.: 13/0254-1
- Batch No.: LJ-008-09-136
- pH: ca. 5 (undiluted test material, moistened with water)

Test animals

Species:
other: not applicable (in vitro test)
Strain:
other: not applicable (in vitro test)

Test system

Type of coverage:
other: not applicable (in vitro test)
Preparation of test site:
other: not applicable (in vitro test)
Vehicle:
unchanged (no vehicle)
Controls:
other: not applicable (in vitro test)
Amount / concentration applied:
see "Any other information on materials and methods incl. tables"
Duration of treatment / exposure:
see "Any other information on materials and methods incl. tables"
Observation period:
see "Any other information on materials and methods incl. tables"
Number of animals:
not applicable (in vitro test)
Details on study design:
TEST SYSTEM:
Three dimensional human epidermis model
The EpiDermTM model consists of normal, human-derived epidermal keratinocytes which have been cultured to form a multi layered, highly differentiated model of the human epidermis. It consists of organized basal, spinous and granular layers, and a multi-layered stratum corneum containing intercellular lamellar lipid layers arranged in patterns analogous to those found in vivo. The EpiDermTM tissues (surface 0.6 cm²) are cultured on specially prepared cell culture inserts (MILLICELLs, 10 mm ∅) and commercially available as kits (EpiDerm™ 200), containing 24 tissues on shipping agarose.

Results and discussion

In vitro

Resultsopen allclose all
Irritation / corrosion parameter:
other: other: mean tissue viability (%)
Value:
111
Remarks on result:
other:
Remarks:
Basis: other: Thane 003-6. Remarks: no potential for skin irritation. (migrated information)
Irritation / corrosion parameter:
other: other: mean tissue viability (%)
Value:
100
Remarks on result:
other:
Remarks:
Basis: other: negative control. Remarks: no potential for skin irritation. (migrated information)
Irritation / corrosion parameter:
other: other: mean tissue viability
Value:
3
Remarks on result:
other:
Remarks:
Basis: other: positive control: 5% SDS. Remarks: skin irritation potential. (migrated information)

In vivo

Irritant / corrosive response data:
The substance is not able to reduce MTT directly. The mean viability of the test substance treated tissues determined after an exposure period of 1 hour with about 42 hours post-incubation was 111%.

Any other information on results incl. tables

Results from EpiDerm(TM) Skin irritation test:

Test substance

 

Tissue 1

Tissue 2

Tissue 3

Mean

SD

NC

mean OD570

2.340

2.311

2.223

2.291

 

viability (% of NC)

102.1

100.9

97.0

100

2.66

Thane 003 -6

mean OD570

2.500

2.476

2.622

2.533

 

viability (% of NC)

109.1

108.1

114.5

111

3.42

PC

mean OD570

0.075

0.066

0.0836

0.075

 

viability (% of NC)

3.3

2.9

3.6

3

0.37

NC, negative control; PC, positive control

Applicant's summary and conclusion